Mera Pharmaceuticals Stock Analysis
| MRPI Stock | USD 0.0001 0.00 0.00% |
Mera Pharmaceuticals' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Mera Pharmaceuticals' financial risk is the risk to Mera Pharmaceuticals stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Mera Pharmaceuticals' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Mera Pharmaceuticals is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Mera Pharmaceuticals to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Mera Pharmaceuticals is said to be less leveraged. If creditors hold a majority of Mera Pharmaceuticals' assets, the Company is said to be highly leveraged.
Mera Pharmaceuticals is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Mera Pharmaceuticals pink sheet analysis is to determine its intrinsic value, which is an estimate of what Mera Pharmaceuticals is worth, separate from its market price. There are two main types of Mera Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Mera Pharmaceuticals pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Mera Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Mera |
Mera Pink Sheet Analysis Notes
The company had not issued any dividends in recent years. Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada. Mera Pharma is traded on OTC Exchange in the United States.The quote for Mera Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Mera Pharmaceuticals contact Benny Doro at 604 500 4157 or learn more at https://www.merapharma.com.Mera Pharmaceuticals Investment Alerts
| Mera Pharmaceuticals generated a negative expected return over the last 90 days | |
| Mera Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Mera Pharmaceuticals currently holds 299.14 K in liabilities. Mera Pharmaceuticals has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mera Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Mera Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mera Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mera to invest in growth at high rates of return. When we think about Mera Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 302.62 K. Net Loss for the year was (5.58 K) with profit before overhead, payroll, taxes, and interest of 286.36 K. | |
| Mera Pharmaceuticals currently holds about 4.32 K in cash with (71.84 K) of positive cash flow from operations. |
Mera Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 222.92 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mera Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Mera Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mera Pharmaceuticals, as well as the relationship between them.Mera Pharmaceuticals Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Mera Pharmaceuticals price series with the more recent values given greater weights.
Mera Pharmaceuticals Outstanding Bonds
Mera Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mera Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mera bonds can be classified according to their maturity, which is the date when Mera Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US58733RAF91 Corp BondUS58733RAF91 | View | |
| US58733RAE27 Corp BondUS58733RAE27 | View |
Mera Pharmaceuticals Debt to Cash Allocation
Mera Pharmaceuticals currently holds 299.14 K in liabilities. Mera Pharmaceuticals has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mera Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Mera Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mera Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mera to invest in growth at high rates of return. When we think about Mera Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Mera Pharmaceuticals Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Mera Pharmaceuticals' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Mera Pharmaceuticals, which in turn will lower the firm's financial flexibility.Mera Pharmaceuticals Corporate Bonds Issued
Most Mera bonds can be classified according to their maturity, which is the date when Mera Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Mera Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Mera Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mera shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Mera Pharmaceuticals. By using and applying Mera Pink Sheet analysis, traders can create a robust methodology for identifying Mera entry and exit points for their positions.
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada. Mera Pharma is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Mera Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Complementary Tools for Mera Pink Sheet analysis
When running Mera Pharmaceuticals' price analysis, check to measure Mera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mera Pharmaceuticals is operating at the current time. Most of Mera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Mera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Mera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |